Clinical Cohort Data on Metabolic Syndrome and Minimal Hepatic Encephalopathy in Cirrhosis

A retrospective cohort of 127 patients with cirrhosis and portal hypertension, used to investigate associations between metabolic syndrome and minimal hepatic encephalopathy. The dataset includes clinical measurements such as fasting blood glucose and Child–Pugh grade, with analyses performed using logistic and Poisson regression. It was authored by Xinyi Ding and last updated on 2026-05-20.

Use Cases

• Identify risk factors for minimal hepatic encephalopathy based on metabolic markers like fasting blood glucose.
• Model the nonlinear dose-response relationship between blood glucose levels and encephalopathy risk.
• Analyze correlations between blood glucose and cognitive test performance (e.g., DST and SDT subtests).
• Validate clinical predictors such as age and Child–Pugh grade for patient risk stratification.

Strengths

• Includes data from 127 patients, a defined cohort size for a clinical study.
• Provides specific prevalence figures (17.3% for MHE) and statistically significant results (e.g., P < 0.05 for FBG as a risk factor).
• Contains detailed analytical results, including an inflection point for FBG at 8.36 mmol/L and odds ratios for key variables.

Limitations

• Row count and column-level documentation are unknown, which limits suitability assessment.
• The dataset is very small at 19.2 KB, indicating limited scope.
• Description metadata is limited; actual data quality and structure require manual inspection after download.

Provenance

Source

figshare, author Xinyi Ding

Collection Method

Retrospective cohort study enrolling patients with cirrhosis and portal hypertension.

Freshness

Last updated 2026-05-20 05:57:46; freshness should be verified.